Bystolic

AbbVie notches reprieve in antitrust case involving blood pressure med snagged in $63B Allergan megamerger
AbbVie notches reprieve in antitrust case involving blood pressure med snagged in $63B Allergan megamerger
Fierce Pharma
AbbVie
antitrust
Bystolic
generics
Allergan
Flag link:
The top 10 drugs losing U.S. exclusivity in 2021
The top 10 drugs losing U.S. exclusivity in 2021
Fierce Pharma
patents
Lucentis
Bystolic
Vascepa
Narcan
Brovana
Sutent
Saphris
Amitza
Feraheme
Flag link:
Forest recalls another 90,000-plus bottles of Bystolic
Forest recalls another 90,000-plus bottles of Bystolic
Fierce Pharma Manufacturing
Forest Labs
product recalls
Bystolic
Flag link:
Forest Labs Seeks Bystolic-Diovan Approval
Forest Labs Seeks Bystolic-Diovan Approval
Yahoo/Zacks.com
Bystolic
Diovan
Forest Labs
hypertension
Flag link:
Forest Labs says trial results positive for hypertension drug
Forest Labs says trial results positive for hypertension drug
Reuters
Forest Labs
Bystolic
Flag link:
Forest Labs says Bystolic approved in Canada
Forest Labs says Bystolic approved in Canada
Yahoo/AP
Forest Labs
Bystolic
Canada
Flag link:
Forest Labs says Canadian regulators approved its high blood pressure drug Bystolic
Forest Labs says Canadian regulators approved its high blood pressure drug Bystolic
Yahoo/AP
Forest Labs
Canada
antihypertensives
Bystolic
Flag link:
Forest Labs Settles BYSTOLIC Patent Lawsuit
Forest Labs Settles BYSTOLIC Patent Lawsuit
Motley Fool
Bystolic
patents
Forest Labs
settlements
Flag link:
Forest Laboratories, Inc. Announces Settlement Agreement with Hetero Labs Ltd. in BYSTOLIC® Patent Litigation
Forest Laboratories, Inc. Announces Settlement Agreement with Hetero Labs Ltd. in BYSTOLIC® Patent Litigation
Business Wire
Forrest
Hetero Labs
Bystolic
generics
patents
lawsuits
Flag link:
Forest buys hypertension drug rights from J&J
Forest buys hypertension drug rights from J&J
Reuters
Forest
JNJ
antihypertensives
Bystolic
Flag link:
Forest Laboratories Receives Decision From FDA For Supplemental New Drug Application For Bystolic(R)
Forest Laboratories Receives Decision From FDA For Supplemental New Drug Application For Bystolic(R)
Medical News Today
Forrest
Bystolic
heart failure
Flag link:
FDA panel rejects new use for Forest heart drug
FDA panel rejects new use for Forest heart drug
Yahoo/AP
FDA
Forest Labs
Bystolic
Flag link:
US FDA staff against wider approval of Forest drug
US FDA staff against wider approval of Forest drug
Reuters
Forest Labs
FDA
Bystolic
Flag link: